Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-12-01–present
Amir Dossal
Board Member
Apimeds Pharmaceuticals US, Inc. (APUS)Equibles does not estimate personal net worth.
Get an email with a short summary when Apimeds Pharmaceuticals US, Inc. publishes a filing, an earnings call transcript or a press release.
Get APUS alertsAbout Amir Dossal
Amir Dossal is recorded as Board Member at Apimeds Pharmaceuticals US, Inc. (APUS) since December 1, 2025. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed December 10, 2025 that Amir Dossal resigned as Independent Director, effective December 5, 2025. Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed December 2, 2025 that Amir Dossal was appointed Company Director Designee, effective December 1, 2025. Apimeds Pharmaceuticals US, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Apimeds Pharmaceuticals US, Inc. includes Sungjoon Chae (CEO and Board Member), Vin Menon (CEO and Board Member), Youngjik Cho (CEO, Chairman and Board Member) and 3 others.
“On December 5, 2025, Dr. Vin Menon, a Director of Apimeds Pharmaceuticals US, Inc. (the "Company"), and Amir A. Dossal, an Independent Director of the Company, resigned from their positions on the Company's Board of Directors.”
“the Company designated two individuals, Dr. Vin Menon and Amir Dossal (the "Company Director Designees"), to be appointed as directors to replace the vacancies on the Board created by the Resigning Directors, and the Company Director Designees were appointed to the Board effective as of the Effective Time.”
Affiliation history
-
Current
2025-12-01–present
-
2025-12-01–2025-12-05
Company network
Leadership on record at Apimeds Pharmaceuticals US, Inc.
- Sungjoon Chae CEO, Board Member
- Vin Menon CEO, Board Member
- Youngjik Cho CEO, Chairman, Board Member
- Eric Sherb CFO
- Junyoung Yu Board Member
- Minguk Ji Board Member